Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab

Neurodegenerative Disease Management
Eva Costa ArpínManuela Lema Bouzas

Abstract

To evaluate the effect of natalizumab on progression of brain atrophy in multiple sclerosis (MS) patients and to search for a clinical or radiological marker of progression of brain atrophy. We retrospectively recorded demographic and clinical data, as well as the corpus callosum index (CCI) using MRI, in MS patients treated with natalizumab for 1-4 years. In the study population (n = 29), baseline mean CCI was 0.37 ± 0.04 and final CCI 0.36 ± 0.04. 17 patients did not develop brain atrophy during follow-up. There was no statistically significant relationship between progression of atrophy and clinical and radiological parameters. Natalizumab may have a neuroprotective effect.

References

Jul 30, 1999·Journal of Neuroimmunology·J H Simon
Feb 15, 2002·Brain : a Journal of Neurology·D T ChardD H Miller
Jun 5, 2002·Current Opinion in Neurology·Frederik Barkhof
Jan 3, 2003·The New England Journal of Medicine·David H MillerUNKNOWN International Natalizumab Multiple Sclerosis Trial Group
Jun 14, 2003·Brain : a Journal of Neurology·Michael SailerAnders Dale
Jul 2, 2004·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Robert Zivadinov, Rohit Bakshi
Jan 24, 2006·Lancet Neurology·Robert A Bermel, Rohit Bakshi
Mar 3, 2006·The New England Journal of Medicine·Chris H PolmanUNKNOWN AFFIRM Investigators
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Apr 25, 2007·Neurology·D H MillerUNKNOWN AFFIRM Investigators
Apr 28, 2007·Multiple Sclerosis : Clinical and Laboratory Research·B AudoinD H Miller
Dec 21, 2007·Arquivos de neuro-psiquiatria·Fernando Faria Andrade FigueiraAngela Correa Marques da Silva
May 13, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·R G HenryD Pelletier
Jun 19, 2008·Annual Review of Neuroscience·Bruce D Trapp, Klaus-Armin Nave
Dec 23, 2008·Journal of the Neurological Sciences·Richard A RudickElizabeth Fisher
Feb 10, 2009·Journal of the Neurological Sciences·Declan Chard, David Miller
Feb 10, 2009·Journal of the Neurological Sciences·Deepa Preeti RamasamyRobert Zivadinov
Jun 3, 2009·Nature Reviews. Neurology·Frederik BarkhofStephen C Reingold
Mar 4, 2010·Journal of Neurology·Ozgür YaldizliNorman Putzki
Mar 14, 2012·Advances in Experimental Medicine and Biology·Elżbieta Miller
Mar 24, 2012·Lancet Neurology·Massimo FilippiUNKNOWN Attendees of the Correlation between Pathological MRI findings in MS workshop
May 10, 2012·Multiple Sclerosis : Clinical and Laboratory Research·F RinaldiP Gallo
Sep 26, 2012·Journal of the Neurological Sciences·Luca ProsperiniCarlo Pozzilli
Oct 13, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E PortaccioM P Amato
Oct 16, 2012·Brain : a Journal of Neurology·James KolasinskiHeidi Johansen-Berg
Nov 17, 2012·Lancet Neurology·Jeroen J G GeurtsRichard A Rudick
Jan 16, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Angela Vidal-JordanaXavier Montalban
Mar 19, 2014·Nature Reviews. Neurology·Manuel A FrieseLars Fugger
Sep 16, 2014·Journal of the Neurological Sciences·Shahamat TauhidRohit Bakshi
Feb 12, 2015·Translational Neurodegeneration·Kristi M AndersonR Lee Mosley

❮ Previous
Next ❯

Citations

Jan 28, 2017·Neurodegenerative Disease Management·Laura Dormer
Apr 8, 2020·Auto- Immunity Highlights·Athina AndravizouGeorgios M Hadjigeorgiou

❮ Previous
Next ❯

Software Mentioned

SPSS
PASW Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
R AlroughaniS F Ahmed
Arquivos de neuro-psiquiatria
Maria Lucia Vellutini Pimentel
© 2022 Meta ULC. All rights reserved